COMBINED CHEMOTHERAPY FOR RECURRENT AND METASTATIC NASOPHARYNGEAL CARCINOMA

被引：8
|
作者：
AIROLDI, M
PEDANI, F
GABRIELE, P
GIORDANO, C
CAVALOT, A
BRANDO, V
机构：
来源：
JOURNAL OF CHEMOTHERAPY | 1989年 / 1卷 / 04期
关键词：
D O I：
10.1080/1120009X.1989.11738907
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：272 / 276
页数：5
相关论文
共 50 条
  • [21] Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy
    Peng, Pei-Jian
    Ou, Xue-Qing
    Chen, Zhi-Bin
    Liao, Hai
    Peng, Yu-Long
    Wang, Si-Yang
    Zhang, Hong-Yu
    Lin, Zhong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (02) : 323 - 328
  • [22] Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma The JUPITER-02 Randomized Clinical Trial
    Mai, Hai-Qiang
    Chen, Qiu-Yan
    Chen, Dongping
    Hu, Chaosu
    Yang, Kunyu
    Wen, Jiyu
    Li, Jingao
    Shi, Yingrui
    Jin, Feng
    Xu, Ruilian
    Pan, Jianji
    Qu, Shenhong
    Li, Ping
    Hu, Chunhong
    Liu, Yi-Chun
    Jiang, Yi
    He, Xia
    Wang, Hung-Ming
    Lim, Wan-Teck
    Liao, Wangjun
    He, Xiaohui
    Chen, Xiaozhong
    Wang, Siyang
    Yuan, Xianglin
    Li, Qi
    Lin, Xiaoyan
    Jing, Shanghua
    Chen, Yanju
    Lu, Yin
    Hsieh, Ching-Yun
    Yang, Muh-Hwa
    Yen, Chia-Jui
    Samol, Jens
    Luo, Xianming
    Wang, Xiaojun
    Tang, Xiongwen
    Feng, Hui
    Yao, Sheng
    Keegan, Patricia
    Xu, Rui-Hua
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (20): : 1961 - 1970
  • [23] A phase II trial of gefitinib in recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
    Chua, D. T.
    Sham, J.
    Au, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Toripalimab plus chemotherapy in American patients with recurrent or metastatic nasopharyngeal carcinoma: A cost-effectiveness analysis
    Lian, Dai
    Gan, Yuling
    Xiao, Dunming
    Xuan, Dennis
    Chen, Yingyao
    Yang, Yi
    CANCER MEDICINE, 2024, 13 (10):
  • [25] Safety and efficacy of radiotherapy combined with chemotherapy for recurrent metastatic renal pelvic and ureteral carcinoma
    Liu, Ming-Zhu
    Li, Xiao-Ying
    Lyu, Feng
    Gao, Xian-Shu
    Chen, Jia-Yan
    Gao, Yan
    Xie, Mu
    Ren, Xue-Ying
    Ma, Ming-Wei
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [26] Safety and Efficacy of Radiotherapy Combined with Chemotherapy for Recurrent Metastatic Renal Pelvic and Ureteral Carcinoma
    Liu, M. Z.
    Li, X. Y.
    Gao, X. S.
    Ma, M. W.
    Li, H. Z.
    Lyu, F.
    Xie, M.
    Chen, J.
    Ren, X.
    Gao, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E409 - E409
  • [27] Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
    Humber, C
    Tierney, J
    Symonds, P
    Collingwood, M
    Kirwan, J
    Williams, C
    Green, J
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (03):
  • [28] Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
    Vale, Claire L.
    Tierney, Jayne
    Bull, Sarah J.
    Symonds, Paul R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (08):
  • [29] Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
    Humber, C.
    Tierney, J.
    Symonds, P.
    Collingwood, M.
    Kirwan, J.
    Williams, C.
    Green, J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [30] Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study
    Mo, Yunyan
    Pan, Yufei
    Zhang, Bin
    Zhang, Jian
    Su, Yixin
    Liu, Zhengchun
    Luo, Meiqing
    Qin, Guanjie
    Kong, Xiangyun
    Zhang, Rongjun
    Pan, Yu
    Liang, Yi
    Wang, Defeng
    Wei, Yuejia
    Chen, Hengwei
    Jiang, Wei
    FRONTIERS IN IMMUNOLOGY, 2024, 14
12345